E137: Inflation cools, market rips, Ripple/MSFT beat regulators, NATO summit, cocktails of youth
Key takeaways
-
Chamath Palihapitiya’s central market call was that stocks could rise materially even if interest rates stayed higher for longer. He argued trillions parked defensively would rotate into growth before Fed cuts, while David Sacks countered that persistently higher rates would restrain valuations.
-
The sharper software argument was that cost cutting had bought time, not fixed weak SaaS economics. Chamath said rapid feature copying keeps many firms on an expensive treadmill without durable profits; Sacks countered that category leaders retain exceptional gross margins and defensible distribution advantages.
-
High borrowing costs were already showing up clearly in cars, where financing dominates demand. The hosts cited 80% of new-car purchases being financed, average loan rates rising from roughly 3.7% to 7%, and used-car prices falling 4.2% in one month.
-
Ripple’s court ruling was mixed, not a blanket declaration that XRP lay outside securities law. The judge treated $728.9 million of direct sales to sophisticated buyers as unregistered securities but exchange sales differently; Jason Calacanis said Brad Garlinghouse texted him that Ripple felt vindicated.
-
The FTC’s Microsoft–Activision loss pushed the discussion toward narrower antitrust enforcement rather than broad resistance to tech acquisitions. Sacks argued suppressing M&A can damage startup exits, while the hosts favored targeting conduct such as bundling, interoperability restrictions and deceptive subscription practices.
-
The Ukraine discussion’s most concrete point was the strain on US production of 155mm artillery shells. Sacks cited output rising from roughly 14,000 monthly to 20,000–30,000, with a much higher target years away, and connected the shortage to Washington’s decision to supply cluster munitions.
-
Ukraine’s NATO membership remained the central fault line at the Vilnius summit, with no immediate invitation or timetable agreed. The episode emphasized Article 5 escalation risks behind Biden’s resistance, while NATO instead removed the Membership Action Plan requirement and created a NATO–Ukraine Council. (NATO)
-
The science segment highlighted six small-molecule cocktails that rejuvenated aged cells in laboratory experiments, offering a possible alternative to gene-based reprogramming. Friedberg said they reproduced aspects of short Yamanaka-factor treatment without viral delivery, but the evidence discussed was cellular research—not proof that an anti-aging pill works in humans.